» Articles » PMID: 24963567

Cryptogenic Stroke and Underlying Atrial Fibrillation

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2014 Jun 26
PMID 24963567
Citations 698
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Current guidelines recommend at least 24 hours of electrocardiographic (ECG) monitoring after an ischemic stroke to rule out atrial fibrillation. However, the most effective duration and type of monitoring have not been established, and the cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in 20 to 40% of cases (cryptogenic stroke). Detection of atrial fibrillation after cryptogenic stroke has therapeutic implications.

Methods: We conducted a randomized, controlled study of 441 patients to assess whether long-term monitoring with an insertable cardiac monitor (ICM) is more effective than conventional follow-up (control) for detecting atrial fibrillation in patients with cryptogenic stroke. Patients 40 years of age or older with no evidence of atrial fibrillation during at least 24 hours of ECG monitoring underwent randomization within 90 days after the index event. The primary end point was the time to first detection of atrial fibrillation (lasting >30 seconds) within 6 months. Among the secondary end points was the time to first detection of atrial fibrillation within 12 months. Data were analyzed according to the intention-to-treat principle.

Results: By 6 months, atrial fibrillation had been detected in 8.9% of patients in the ICM group (19 patients) versus 1.4% of patients in the control group (3 patients) (hazard ratio, 6.4; 95% confidence interval [CI], 1.9 to 21.7; P<0.001). By 12 months, atrial fibrillation had been detected in 12.4% of patients in the ICM group (29 patients) versus 2.0% of patients in the control group (4 patients) (hazard ratio, 7.3; 95% CI, 2.6 to 20.8; P<0.001).

Conclusions: ECG monitoring with an ICM was superior to conventional follow-up for detecting atrial fibrillation after cryptogenic stroke. (Funded by Medtronic; CRYSTAL AF ClinicalTrials.gov number, NCT00924638.).

Citing Articles

Computer-Assisted Electrocardiogram Analysis Improves Risk Assessment of Underlying Atrial Fibrillation in Cryptogenic Stroke.

Viliani D, Cecconi A, Spinola Tena M, Vera A, Ximenez-Carrillo A, Ramos C Cardiol Res. 2025; 16(2):120-129.

PMID: 40051669 PMC: 11882229. DOI: 10.14740/cr2016.


Wearables and Atrial Fibrillation: Advances in Detection, Clinical Impact, Ethical Concerns, and Future Perspectives.

Francisco A, Pascoal C, Lamborne P, Morais H, Goncalves M Cureus. 2025; 17(1):e77404.

PMID: 39949464 PMC: 11822239. DOI: 10.7759/cureus.77404.


Wear Your Heart on Your Sleeve: Smart Textile ECG Wearables for Comfort, Integration, Signal Quality and Continuous Monitoring in Paroxysmal Atrial Fibrillation.

Avanu A, Dodi G Sensors (Basel). 2025; 25(3).

PMID: 39943314 PMC: 11820156. DOI: 10.3390/s25030676.


A Year in Review: Atrial Fibrillation 2024.

Ahmad A, Taranto L, Karnik A, Doshi R J Innov Card Rhythm Manag. 2025; 16(1):6136-6140.

PMID: 39897725 PMC: 11784398. DOI: 10.19102/icrm.2025.16016.


Combining D-dimer and LDL/HDL ratio to predict the absence of atrial fibrillation in patients with an Implantable Loop Recorder for embolic stroke of Undetermined source.

Yoshikawa K, Asano T, Onishi Y, Takai Y, Sugiyama H, Arai S Int J Cardiol Heart Vasc. 2025; 56:101611.

PMID: 39897416 PMC: 11787485. DOI: 10.1016/j.ijcha.2025.101611.